Header Logo

Connection

Steven Gitelis to Osteosarcoma

This is a "connection" page, showing publications Steven Gitelis has written about Osteosarcoma.
Connection Strength

0.726
  1. The prognostic significance of lymphovascular tumor invasion in localized high-grade osteosarcoma: Outcomes of a single institution over 10 years. J Surg Oncol. 2021 Jun; 123(7):1624-1632.
    View in: PubMed
    Score: 0.186
  2. The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis. Cancer Biol Ther. 2017 Nov 02; 18(11):895-903.
    View in: PubMed
    Score: 0.145
  3. Frequent complications and severe bone loss associated with the repiphysis expandable distal femoral prosthesis. Clin Orthop Relat Res. 2015 Mar; 473(3):831-8.
    View in: PubMed
    Score: 0.123
  4. Inhibition of the Wnt-?-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun. 2013 Feb 08; 431(2):274-9.
    View in: PubMed
    Score: 0.106
  5. Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene. 2007 Jan 15; 386(1-2):131-8.
    View in: PubMed
    Score: 0.068
  6. The human homolog of yeast SEP1 is a novel candidate tumor suppressor gene in osteogenic sarcoma. Gene. 2002 Oct 02; 298(2):121-7.
    View in: PubMed
    Score: 0.052
  7. Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor. Oncotarget. 2016 May 10; 7(19):27511-26.
    View in: PubMed
    Score: 0.033
  8. Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation. Cell Growth Differ. 2002 Sep; 13(9):397-407.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.